Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/PTP stock hub

ETR/PTP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/PTPis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
53.5M
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/PTP
In the news

Latest news · ETR/PTP

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 15.7P75 20.2
Trailing P/En/a
P25 16.4P50 20.9P75 30.4
ROE-40.4
P25 -6.7P50 8.5P75 17.2
ROIC-30.2
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/PTP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
146
Groups with data
10
Currency
EUR
Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
DE
Employees
61
Employees Change
-14%
Employees Change Percent
-18.67
Enterprise value
EUR 48.4M
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Biotechnology
Isin
DE000A40AEG0
Last refreshed
2026-05-10
Market cap
EUR 53.5M
Price
EUR 2.16
Price currency
EUR
Rev Per Employee
6,508.2x
Sector
Healthcare
Sic
2835
Symbol
etr/PTP
Website
https://www.pentixapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-29.29%
EV Earnings
-3.08x
EV/FCF
-3.18x
EV/Sales
121.83x
FCF yield
-28.44%
P/B ratio
1.66x
P/S ratio
134.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Gross Profit
EUR -5.8M
Net Income
EUR -15.7M
Pretax Margin
-4,681.11%
Profit Per Employee
EUR -257,049
ROA
-24.25
ROCE
-49.07
ROE
-40.44
ROIC
-30.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
-25.53%
Revenue Growth
-74.37x
Revenue Growth Q
-80.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
EUR 0.01
Assets
EUR 41.2M
Cash
EUR 5.2M
Current Assets
EUR 6M
Current Liabilities
EUR 3.5M
Equity
EUR 32.2M
Interest Coverage
-108.4
Liabilities
EUR 9M
Long Term Assets
EUR 35.2M
Long Term Liabilities
EUR 5.6M
Net Cash
EUR 5.2M
Net Cash By Market Cap
EUR 9.64
Net Cash Growth
-78.62%
Net Debt Equity
EUR -0.16
Tangible Book Value
EUR 781,000
Tangible Book Value Per Share
EUR 0.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.15
Net Working Capital
EUR -1.8M
Quick ratio
1.82
Working Capital
EUR 3.4M
Working Capital Turnover
EUR 0.04

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

33
MetricValue
1Y total return
-25.52%
200-day SMA
1.82
50-day SMA
2
50-day SMA vs 200-day SMA
50over200
All Time High
5.15
All Time High Change
-58.06%
All Time High Date
2024-10-03
All Time Low
1.3
All Time Low Change
66.15%
All Time Low Date
2025-11-21
ATR
0.1
Beta1y
0.5
Beta2y
0.92
Ch YTD
45.75
High
2.17
High52
3.7
High52 Date
2026-02-20
High52ch
-41.62%
Low
2.1
Low52
1.3
Low52 Date
2025-11-21
Low52ch
66.15%
Ma50ch
8%
Price vs 200-day SMA
18.88%
RSI
60.4
RSI Monthly
40.13
RSI Weekly
55.95
Sharpe ratio
-0.25x
Sortino ratio
-0.34
Tr YTD
45.75
Tr1m
5.88%
Tr1w
2.37%
Tr3m
13.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -18.8M
Operating margin
-4,724.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
17,105,056%
Shares Insiders
0.2%
Shares Institutions
6.54%
Shares Out
24,783,048
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

47
MetricValue
Adjusted FCF
EUR -15.2M
Average Volume
4,916.7x
Bv Per Share
1.3
CAPEX
EUR -20,000
Ch1m
5.88
Ch1w
2.37
Ch1y
-25.52
Ch3m
13.33
Ch6m
39.72
Change
-0.46%
Change From Open
1.89
Close
2.17
Days Gap
-2.3
Depreciation Amortization
261,000
Dollar Volume
12,029
Earnings Date
2026-08-06
EBIT
EUR -18.8M
EBITDA
EUR -18.5M
EPS
EUR -0.64
F Score
1
FCF
EUR -15.2M
FCF EV Yield
-31.47x
FCF Per Share
EUR -0.61
Financing CF
3,000,000
Fiscal Year End
December
Founded
2,019
Income Tax
EUR -2.9M
Investing CF
-20,000
Is Primary Listing
1
Last Earnings Date
2026-03-26
Last Report Date
2025-12-31
Ma150
1.82
Ma150ch
18.81%
Ma20
2.07
Ma20ch
4.5%
Net CF
-12,227,000
Next Earnings Date
2026-08-06
Open
2.12
Position In Range
85.71
Ppne
36,000
Price Date
2026-05-08
Ptbv Ratio
68.54
Relative Volume
1.13x
Revenue
397,000x
Tax By Revenue
-731.49x
Tr6m
39.72%
Volume
5,569
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/PTP pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/PTP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-25.5%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ETR/PTP?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.5%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

ETR/PTP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.4
Neutral momentum band
Price vs 200-day MA
+18.9%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.25
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/PTP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/PTP stock rating?

etr/PTP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/PTP analysis?

The full report lives at /stocks/etr/PTP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/PTP?

The latest report frames etr/PTP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/PTP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.